News
Best practice industry content from your peers
eLabNext and US Lab Partners Form Strategic Partnership to Enhance Digital Infrastructure of Emerging and Established Life Science Companies
eLabNext, an Eppendorf Group Company offering a flexible Digital Laboratory Platform equipped with a Laboratory Inventory Management System (LIMS) and Electronic Lab Notebook (ELN), has entered into a “preferred vendor” partnership with US Lab Partners, a strategic consulting and advisory firm that provides life sciences companies with best-in-class labs, facilities, and EH&S programs.
US Lab Partners engages with life science organizations at various points during the corporate life cycle to provide the infrastructure life sciences companies require to solve complex issues, pursue opportunities, achieve measurable cost savings, and serve their employees and stakeholders. The partnership ensures that US Lab Partners clients, including academic spin-outs and established biotech and pharma companies building new capabilities, are equipped with the digital capabilities to support laboratory workflows, sample management, compliance, and other operational necessities alongside the physical facilities and vendor relationships.
“We help our clients develop a roadmap for their project, implement a strategic plan, and manage every step of the process using our pre-existing ecosystem of partners,” explains Demet Aybar, CEO and Founder of US Lab Partners. “Adding eLabNext as a valued member of that ecosystem means that we provide our clients with the best sample, inventory, equipment, and protocol management system available so their research can be as successful as possible.”
“Like eLabNext, the team at US Lab Partners has a background in science, and we share a strategic vision: To help scientific teams in life sciences achieve their full potential by providing the best solutions in the industry,” states Zareh Zurabyan, Head of eLabNext, Americas. “This alignment makes us the perfect partners. We’re excited to enhance the efficiency of US Lab Partners’ clients through laboratory digitalization.”
About US Lab Partners
US Lab Partners is a strategic consulting and advisory firm that aims to help scientific teams in the life sciences achieve their full potential by providing the best products, services, and solutions in the industry. Their team of laboratory and facility experts provides the lab operations, facilities, and EH&S infrastructure life sciences companies require to solve complex issues, pursue opportunities, achieve measurable cost savings, and serve their employees and stakeholders.
For more information about US Lab Partners, please visit www.uslabpartners.com.
Press contact:
Name: Demet Aybar
CEO and Founder of US Lab Partners, LLC
Email: contact@uslabpartners.com
Posted August 7, 2024
Demet Aybar, Founder and Chief Executive Officer at US Lab Partners LLC and DKSCientific, has been recognized by Marquis Who’s Who Top Executives for dedication, achievements, and leadership in laboratory administration.
With nearly 25 years of experience to her credit, Ms. Aybar has excelled as the founder and chief executive officer for US Lab Partners LLC and DKSCientific since 2023. Prior to these positions, she was active as a senior research associate in biological sciences with Ribon Therapeutics from 2016 to 2018, a laboratory operations manager for Repertoire Immune Medicines from 2018 to 2020, an associate director of lab operations for Scholar Rock from 2020 to 2021, the director of facilities, lab operations and E&S for Endolytix Technology Inc. from 2021 to 2022 and the director of facilities, lab operations and EH&S for Strand Therapeutics from 2022 to 2023. She previously served as a clinical laboratory scientist and customer service liaison for Gelisim Biochemical Laboratories in Turkey from 2000 to 2001, a research and teaching assistant at Marmara University from 2002 to 2004, a research specialist in the Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill from 2006 to 2014, a research investigator for a Synereca Pharmaceuticals Inc.-sponsored project at the University of North Carolina at Chapel Hill from 2011 to 2014, and the laboratory operations and project manager for the Harvard-MIT Biomedical Engineering Center at the Massachusetts Institute of Technology from 2014 to 2016. Ms. Aybar began her career as a clinical laboratory scientist intern at the Farabi Hospital Emergency Biochemistry Laboratory in 1999, a chemist intern at Sagra Special Chocolate Factory in 1999 and an intern and quality control scientist with the Askale Cement Company in 2000.
To support her professional ambitions, Ms. Aybar pursued an education at Karadeniz Technical University, from which she obtained a Bachelor of Science in chemistry in 2000. She concluded her studies at Marmara University in 2005, graduating a Master of Science in analytical chemistry. Attributing her success to her family’s support, her hard work, her detail-oriented nature and her consistent need to improve, she is incredibly proud to have helped biotech companies with their construction during the COVID-19 pandemic. In the coming years, Ms. Aybar hopes to continue helping people to grow while guiding them on their path to success.
Originally posted on September 23, 2023 on Marquis Who’s Who.
